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Ethnopharmacological relevance: Corilagin (b-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-D-glucose) is a
tannin isolated from Phyllanthus niruri (Euphorbiaceae). This plant is well known for their therapeutic
purposes to treat several diseases associated with dolorous process and are used in several ethno-
medicines in tropical and subtropical countries.
Aim of the study: This study was designed to evaluate the anti-hyperalgesic activity of corilagin using
chemically and thermally based nociception models in mice.
Materials and methods: Corilagin was isolated from Phyllanthus niruri (Euphorbiaceae) by extraction
and chromatographic procedures and the anti-hyperalgesic activity was evaluated by using writhing,
formalin, capsaicin, glutamate and hot plate tests in mice.
Results: Corilagin presented activity in acetic acid model with the ID50 calculated value of 6.46 (3.09–
13.51) being about 20.6 fold more potent than acetylsalicylic acid. It also exhibited activity against the
ﬁrst phase of formalin test with ID50 value of 18.38 (15.15–22.59) mmol/kg. In the capsaicin and
glutamate models, corilagin demonstrated signiﬁcant activity at the 3 mg/kg.
Conclusion: The experimental data demonstrated that corilagin exhibits anti-hyperalgesic activity that
may be due to interaction with the glutamatergic system.
& 2013 Elsevier Ireland Ltd. Open access under the Elsevier OA license. 1. Introduction
Phyllanthus niruri Linn., Euphorbiaceae, known in Brazil as
‘‘quebra-pedra’’ and in other Latinoamerican countries as ‘‘chan-
capiedra’’ occurs widely in the tropical and subtropical countries.
Infusion of different parts of this plant and other from the genus
Phyllanthus is frequently used with therapeutic purposes to treat
several diseases particularly disturbances of kidney and urinary
bladder associated with the dolorous process (Calixto et al., 1998;
Khanna et al., 2002; Ranilla et al., 2010; Shanbhag et al., 2010).
Experimental studies have conﬁrmed different pharmacological
properties such as hepatoprotective (Harish and Shivanandappa,
2006), antiplasmodial (Cimanga et al., 2004), antihyperlipemic
(Khanna et al., 2002), antihyperuricemic (Murugaiyah and Chan,
2009) and antioxidant activities (Sarkar et al., 2009). Moreover,
there are quite a few studies reporting the antinociceptive effect
of Phyllanthus niruri (Santos et al., 1994, 1995a, 1995b; Obidike
et al., 2010). The medicinal effects are attributed to the activeduac- ~ao em Cieˆncias Farm-
uticas—NIQFAR, Rua Uruguai
ajaı´, Santa Catarina, Brazil.
uzzi).
r the Elsevier OA license. components present in Phyllanthus niruri, such as lignans
(Murugaiyah and Chan, 2007), ﬂavonoids (Shakil et al., 2008),
terpenoids (Singh et al., 1989) and in particular, tannins (Markom
et al., 2007).
Corilagin (b-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-D-glu-
cose) (Fig. 1), a tannin isolated from several plants, including
Phyllanthus niruri, has also been used as a phytochemical marker
for qualitative and quantitative studies of this plant (Colombo
et al., 2009). Some pharmacological activities of corilagin
have already been described, such as antiatherogenic (Duan
et al., 2005), antioxidant (Chen and Chen, 2011), hepatoprotec-
tive (Kinoshita et al., 2007) and anti-tumor (Hau et al., 2010).
Furthermore, corilagin was also able to inhibit the release of
cytokines such as TNF-a, IL-1b and IL-6 as well as the produc-
tion of nitric oxide, both of which are mediators of inﬂamma-
tion and pain (Okabe et al., 2001; Zhao et al., 2008; Dong et al.,
2010).
Considering that Phyllanthus niruri has already demonstrated
antinociceptive activity in vivo and, that one of the main constituents
of the species is corilagin, which was able to inhibit mediators related
to inﬂammatory pain; and since there is no study evaluating the
antinociceptive properties of the tannin, this study assesses the effects
of corilagin treatment on chemically and thermally based nociception
models in mice.
Fig. 1. Chemical structure of corilagin (b-1-O-galloyl-3,6-(R)-hexahydroxydiphe-
noyl -D-glucose).
Table 1
13C NMR chemical shifts for corilagin in CD3OD
a.
Sudjaroen et al., 2012 Experimental
Glucose
1 95.1 95.1
2 69.4 71.3
3 71.6 71.8
4 62.5 61.7
5 76.2 77.1
6 65.0 65.2
Galloyl
1 120.7 120.4
2 111.0 111.0
3 146.4 146.3
4 140.4 140.9
5 146.4 146.6
6 111.0 111.0
Ring A
1 117.3 117.3
2 125.5 125.5
3 110.3 109.0
4 145.7 145.7
5 138.3 138.3
6 145.5 145.4
7 168.7 168.6
Ring B
1 116.8 116.4
2 125.6 125.7
3 108.4 108.3
4 146.0 146.3
5 137.8 137.7
6 145.4 145.4
7 170.2 170.1
a Obtained in ppm rel. TMS; 1H NMR 300 MHz.
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2.1. Plant material
Phyllanthus niruri L. (Euphorbiaceae) was collected in January
2011 at Praia da Esplanada-Jaguaruna, Santa Catarina, Brazil. The
plant was authenticated by Professor Oscar Iza (UNIVALI) and a
voucher specimen was deposited at the Barbosa Rodrigues Her-
barium (HBR, Itajaı´) under number VC Filho 075.
2.2. Extraction and isolation procedures
The whole plant (337 g, dry weight) was cut into small pieces
and submitted to maceration with methanol at room temperature
for 5 days, giving 30.98 g of the crude extract. 25 g of the extract
was solubilized in methanol/water (2:5 v/v) and extracted with
dichloromethane (3 times, 2:1 v/v) and ethyl acetate (3 times,
2:1 v/v), to give the dichloromethane (4.05 g), ethyl acetate
(5.58 g) and methanol (10.74 g) fractions after evaporation. 1 g
of the ethyl acetate fraction was submitted to chromatography
using silica gel eluted with a dichloromethane/ethyl acetate/
methanol gradient (40:55:5-0:0:100 v/v/v), giving six main
fractions. The third fraction (272.9 mg) was chromatographed
using isocratic ﬂash chromatography (dichloromethane/ethyl acetate/
methanol, 30:50:20 v/v/v), to give pure corilagin (88.4 mg). The
compound with purity grade 495% was identiﬁed by 13C-NMR
spectral data by comparison with those previously reported (Table 1).
2.3. Pharmacological procedures
2.3.1. Animals
Male Swiss mice weighting 25–30 g obtained from the Animal
Facility of the Universidade do Itajaı´ (UNIVALI, Itajaı´, Brazil) were
used in this study. The animals were housed in plastic cages,
under a 12 h light/dark cycle (lights on 7:00 a.m.) at constant
room temperature (23 1C72 1C) and humidity (60–80%) with
water and food ad libitum. The animals were acclimated to the
experimental room at least 1 h before each experiment. The
allocation of animals to the different groups was randomized,
and the experiments were carried out in blind conditions. Each
group was constituted of 6–8 mice; each animal was used in one
experiment only, and sacriﬁced immediately at the end of each
experiment. All the experimental procedures were performed in
accordance with NIH publication no. 85–23—‘‘Principles of
Laboratory Animal Care’’ and with the approval of the UNIVALI
Ethics Committee, under protocol no. 599/2007.
2.3.2. Evaluation of antinociceptive activity in mice
2.3.2.1. Acetic acid-induced writhing test. Groups of mice (8/group)
were treated with different doses of corilagin (1, 3, 6 and 10 mg/kg)
by intraperitonial injection (i.p.) or by oral gavage (50 mg/kg).Control animals received a similar volume of vehicle (10 mL/kg,
0.9% NaCl solution). Acetic acid-induced writhing test (Collier et al.,
1968) consisting of an i.p. injection of 10 mL/kg acetic acid (0.6% in
vehicle) 30 min after treatment of the animals, to cause abdominal
constrictions. Pairs of mice were placed in separate boxes and the
number of abdominal constrictions was cumulatively counted over
a period of 20 min. Antinociception was expressed as the reduction
in the number of abdominal constrictions between the control
animals and the mice pretreated with corilagin.
2.3.2.2. Formalin-induced paw licking test. The procedure was
similar to that described previously (Hunskaar and Hole, 1987;
Sakurada et al., 1993). Animals were treated with corilagin
intraperitoneally at 3, 6, 10 mg/kg or vehicle (10 mL/kg, 0.9%
NaCl solution), 30 min before formalin injection. The observation
chamber was a glass cylinder of 20 cm in diameter, with a mirror
at a 451 angle to allow clear observation of the animal’s paws. The
0.92% aqueous formalin solution was prepared as a 2.5% dilution
of analytical 37% formaldehyde solution in water (Hunskaar and
Hole, 1987). This solution was injected (20 mL) under the surface
of the right hind paw. Two mice (control and treated) were
observed simultaneously from 0 to 30 min following formalin
injection. The amount of time spent licking the injected paw was
recorded and expressed as the total licking time in the early phase
(0–5 min) and late phase (15–30 min) after formalin injection,
representing the tonic and inﬂammatory pain responses,
respectively.
2.3.2.3. Capsaicin-induced nociception. The procedure used was
similar to that described previously (Sakurada et al., 1993).
Animals were placed individually in transparent glass cylinders.
Following the adaptation period, 20 mL of capsaicin solution
Table 2
Effects of different doses of corilagin against acetic acid-induced writhing in mice.
Compound dose (mg/kg i.p.) Inhibition (%) ID50
1 22.2 (74.85)n 4.10 (1.96–8.57) mg/kg or
6.46 (3.09–13.51) mmol/kg3 49.0 (71.59)nn
6 53.5 (73.35)nn
10 57.4 (72.46)nn
Each group represents the mean7SEM of 6–8 experimental values.
n po0.05.
nn po0.01 compared to the respective control values.
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the right hind paw, using a micro-syringe. The animals were
observed individually for 5 min following capsaicin injection. The
amount of time spent licking the injected paw was timed with a
chronometer and was considered as indicative of nociception. The
animals were treated intraperitoneally with corilagin at 3 mg/kg
or vehicle (10 mL/kg, 0.9% NaCl solution) 30 min before
administration of capsaicin.
2.3.2.4. Glutamate-induced nociception. Similarly to the procedure
described by Beirith et al. (2002), in this test animals were treated
with corilagin i.p. at 3 mg/kg or vehicle (10 mL/kg, 0.9% NaCl
solution) 30 min before glutamate injection. A volume of 20 mL
glutamate solution (30 mmol/paw), made up in phosphate
buffered saline (PBS), was injected intraplantarly under the
surface of the right hind paw as described previously. After
injection with glutamate, the animals were individually placed
into glass cylinders of 20 cm in diameter and observed for 0 to
15 min. The time spent licking and biting the injected paw was
timed with a chronometer and considered as indicative of pain.
2.3.2.5. Hot-plate test. The hot-plate test was used to estimate the
latency of responses according to the method described by Eddy
and Leimback (1953) with minor modiﬁcations. The temperature
of the hot-plate was maintained at 5571 1C. The animals were
placed on glass funnels on a heated surface, and the time between
placing the animals and the beginning of licking paws or jumping
was recorded as the response latency index. Reaction time was
recorded before and 30 min after i.p. administration of corilagin
(3 mg/kg i.p.) or the same volume of vehicle (saline 10 mL/kg).
A cut-off time of 20 s was chosen to indicate complete analgesia
and avoid tissue injury.
2.3.3. Measurement of motor performance
2.3.3.1. Rota-rod test. The interference of corilagin on motor
coordination was also evaluated (Duhnam and Miya, 1957). This
test was performed using a horizontal rota-rod device (Letica
Scientiﬁc Instrument, Barcelona, Spain) set to rotate at a constant
speed of 15 rpm. The animals were trained and then selected 24 h
before the test by eliminating those mice that did not remain on
the bar for two consecutive periods of 60 s. The animals were
treated with compound (3 mg/kg, i.p.) or with the same volume of
0.9% NaCl solution (10 mL/kg, i.p.) 30 min before being tested. The
results are expressed as the time (s) the animals remained on the
rota-rod. The cut-off time used was 60 s.
2.3.3.2. Open ﬁeld test. To exclude possible nonspeciﬁc effects of
corilagin on locomotor activity, mice were treated with compound
(3 mg/kg, i.p.) and after 30 min, the locomotor activity was assessed
in the open-ﬁeld test, as described previously (Bortolanza et al.,
2002). The number of squares crossed with all paws (‘‘crossings’’) in
a 6 min session was counted. The control mice received vehicle
(10 mL/kg, i.p. 0.9% NaCl).
2.4. Statistical analysis
The results are presented as mean7SEM, except the mean
ID50 values (i.e. the dose of compound reducing the algesic
responses by 50% compared with the control value) which are
reported as geometric means accompanied by their respective
95% conﬁdence limits. The statistical signiﬁcance between groups
was analyzed by one-way ANOVA followed by Dunnett’s post-
test, unless otherwise stated. P-values of less than 0.05 wereconsidered as indicative of signiﬁcance. ID50 values were deter-
mined by graphical interpolation from individual experiments.
2.5. Drugs
The following drugs were used: capsaicin and glutamate
(Sigma Chemical Company, St. Louis, U.S.A); formalin, acetic acid
(Vetec, Rio de Janeiro, Brazil). The compounds studied, as well as
the reference drugs, were dissolved in 0.9% of NaCl solution, with
the exception of capsaicin, which was dissolved in ethanol, plus
0.9% of NaCl solution. The ﬁnal concentration of ethanol did not
exceed 5% and did not cause any effect ‘‘per se’’.3. Results
3.1. Acetic acid-induced writhing test
The administration of corilagin 1, 3, 6 and 10 mg/kg i.p.
reduced the number of writhing episodes induced by acetic acid
by 22.2, 49.0, 53.5 and 57.4%, respectively, compared to the
control group (Table 2). ID50 calculated value (and its 95%
conﬁdence limits) was 6.46 (3.09–13.51) mmol/kg or 4.10 (1.96–
8.57) mg/kg As oral administration of 50 mg/kg of corilagin did
not reduce acetic acid writhing responses, intraperitoneal admin-
istration was preferred (Data not shown).
3.2. Formalin-induced paw licking test
In the formalin test, intraperitoneal pre-administration
(30 min) of corilagin in different doses (3, 6 and 10 mg/kg)
signiﬁcantly reduced the formalin-induced licking in the early
phase (po0.01), in a dose-dependent way, but not in the late
phase (Fig. 2). The calculated ID50 (and its 95% conﬁdence limits)
was 18.38 (15.15–22.59) mmol/kg or 11.66 mg/kg (9.61–14.33).
The 3 mg/kg corilagin was the lowest dose used in this study
capable of causing a marked inhibition in both, acetic acid and
formalin tests. Therefore, this dose was chosen to be used in the
subsequent tests.
3.3. Capsaicin-induced pain
The effect of corilagin against capsaicin-induced nociception in
mice is shown in Fig. 3A. Signiﬁcant reduction of 32.6% was
observed in the time spent on licking the paw in mice receiving
corilagin at the dose of 3 mg/kg compared to the control group
(po0.01).
3.4. Glutamate-induced nociception
The corilagin dose of 3 mg/kg caused a signiﬁcant inhibi-
tion, 66.2% (po0.01), in the licking and biting behavior in
Fig. 2. Effects of corilagin administered intraperitoneally against formalin induced licking in mice (Panel A: early phase; Panel B: late phase). Each column represents the
mean7SEM (n¼6–8/group). Asterisks denote the signiﬁcance levels, when compared to the control group, *po0.05; **po0.01. ANOVA followed by Dunnett’s test.
Fig. 3. Panel A: Effect of the intraperitoneal administration of corilagin (3 mg/kg) against capsaicin-induced nociception in mice. Panel B: Effect of the intraperitoneal
administration of corilagin (3 mg/kg) against glutamate-induced nociception in mice. Panel C: Effect of the intraperitoneal administration of corilagin (3 mg/kg) on the hot-
plate test in mice. Each column represents the mean7SEM (n¼6–8/group). Asterisks denote the signiﬁcance levels, when compared to the control group, *po0.05;
**po0.01. ANOVA followed by Dunnett’s test.
Fig. 4. Panel A: Effects of corilagin administered intraperitoneally on the rota-rod in mice. Each column represents the mean7SEM (n¼ 6–8/group). Panel B: Effects of
corilagin administered intraperitoneally on the open ﬁeld test. Each column represents the mean7SEM (n¼ 6–8/group). Asterisks denote the signiﬁcance levels, when
compared to the control group, *po0.05, **po0.01. ANOVA followed by Dunnett’s test.
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control group (Fig. 3B).
3.5. Hot-plate test
The i.p. administration of 3 mg/kg of corilagin did not change
the latency time to the nociceptive response of mice in the hot
plate test (Fig. 3C).
3.6. Rota-rod test
As shown in Fig. 4A, corilagin (3 mg/kg i.p.) did not cause
signiﬁcant alterations in the motor performance of mice in the
rota-rod test.3.7. Open ﬁeld test
Mice treated with corilagin (3 mg/kg i.p.) did not demonstrate
a statistical reduction in the number of crossings and rearings
when compared to control group (Fig. 4B).4. Discussion
Considering that corilagin is one of the major constituents of
Phyllanthus niruri and has a wide spectra of biological activities
(Zhao et al., 2008; Chen and Chen, 2011), including anti-
inﬂammatory activity, we investigated, in this work, the anti-
hyperalgesic properties of this tannin using animals models of
pain behavior.
J. Moreira et al. / Journal of Ethnopharmacology 146 (2013) 318–323322The acetic acid-induced writhing test is a classic visceral pain
model commonly used for assessment of potential antinocicep-
tive and anti-inﬂamatory agents (Collier et al., 1968). In this test,
pain is caused by acetic acid directly through the activation of
non-selective cation channels present at primary afferent path-
ways (Julius and Basbaum, 2001) and indirectly via release of
endogenous mediators, including bradykinin, substance P, pros-
taglandins, histamine and others, which are able to increase
vascular permeability, and to stimulate both peripheral nocicep-
tive neurons and nerve terminal of nociceptive ﬁbers (Derardt
et al., 1980; Martinez et al., 1999; Ikeda et al., 2001).
Our results show that corilagin signiﬁcantly reduced acetic
acid writhing responses in a dose-dependent manner, which may
suggest that this tannin attenuates the release of inﬂammatory
endogenous mediators or blocks inﬂammation-promoting recep-
tors, resulting in peripheral anti-hyperalgesic activity. However,
even if acetic acid is a sensitive model for screening analgesic
substances, it constitutes a non-speciﬁc model (Takahashi and
Paz, 1987) and thus other tests such as formalin, capsaicin and
glutamate were conducted to better characterize the anti-
hyperalgesic pharmacology of corilagin. Comparison with pre-
vious results (Santos et al., 1995a, 1995b) indicated that corilagin
was more potent than the hydroalcoholic extract obtained from
this same plant.
The oral administration of corilagin was not able to inhibit the
nociception induced by acetic acid. This result may be due to the
rapid metabolization of corilagin by intestinal microﬂora. It was
demonstrated that the anaerobic incubation of the tannin with rat
fecal suspension led to hydrolysis to several different metabolites,
like gallic acid, ellagic acid and other derivatives. This hydrolysis
seems to not occur by i.p. administration (Ito, 2011).
Two distinct phases constitute the formalin test. The ﬁrst,
called the neurogenic phase, starts immediately after formalin
injection and seems to be elicited by direct activation of C-ﬁbers
(McNamara et al., 2007). The second (or inﬂammatory) phase is a
combination of a peripheral inﬂammatory reaction response
induced by release of nociceptive mediators, and changes in
central processing of pain (Hunskaar and Hole, 1987; Shibata
et al., 1989; Tjølsen et al., 1992). Corilagin produced signiﬁcant
dose-dependent anti-hyperalgesic properties only in the neuro-
genic phase of the formalin test. These ﬁndings strongly suggest
that corilagin could induce changes both in the direct activation
of nociceptors and in the neurogenic pain response induced by
the release of mediators such as bradykinin, 5-hydroxytrypta-
mine, histamine and adenosine triphosphate (Tjølsen et al., 1992;
Sawynok and Liu, 2003). The lack of signiﬁcant activity on the
second phase of formalin test could be due to the hidrophilicity or
high polar surface area of corilagin, which could selectively limit
its passage to the brain (Kelder et al., 1999; Pardridge, 2007).
Nociception evoked by capsaicin occurs by activation of a
ligand-gated cation channel TRPV1 (or VR1 channel) (Caterina
et al., 1997). As a consequence, the release of several chemical
mediators, such as substance P, excitatory amino acids (aspartic
and glutamic acids), neurokinin A, calcitonin gene-related pep-
tide, nitric oxide (NO) and pro-inﬂammatory mediators also
contribute to increase nociception (Sakurada et al., 1993; Teoh
et al., 1996; Mohamad et al., 2010). Our results show that
corilagin signiﬁcantly reduced capsaicin-induced nociception,
suggesting that the tannin may be involved in the antagonism
of the TRPV1 receptor.
Another ﬁnding of our study is that corilagin also inhibited the
nociceptive pain response induced by intraplantar injection of
glutamate into mouse hind paw. Glutamate can act in peripheral,
spinal and supra-spinal areas that are involved in the processing
of nociception. The glutamate peripheral induced-pain response
appears to be mediated through the activation of ionotropicreceptors by N-methyl-D-aspartate (NMDA), a-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid (non-NMDA ligand),
as well as the release of NO or other NO-derived substances. NO
release contributes to enhancing the inﬂammatory reaction
through the induction of the synthesis of pro-inﬂammatory
mediators such as cytokines (Fundytus, 2001; Beirith et al.,
2002; Jesse et al., 2009; Mohamad et al., 2010). Thus, the anti-
hyperalgesic activity of corilagin in the glutamate test may be due
to inhibition of NO production or to the interaction of corilagin
with the glutamatergic system.
Concerning the hot plate test, administration of corilagin 3 mg/kg
i.p. in mice did not exert any change in response latency time to the
thermal nociceptive stimulus when compared to the control group.
Considering that the supraspinal and spinal opioid receptors play a
key role in the hot plate assay, our results suggest that this
compound does not act on the central opioid receptors, nor does it
produce a release of endogenous opioid peptides (Eddy and
Leimback, 1953). Importantly, corilagin at 3 mg/kg i.p. was devoid
of signiﬁcant effects on locomotor activity and motor coordination
in mice (i.e. open ﬁeld and rotarod test, respectively), eliminating the
possibility of non-speciﬁc muscle relaxation and sedative effects in
corilagin-induced antinociception. This observation strongly sug-
gests that the antinociceptive activities of corilagin measured in this
study are pharmacologically speciﬁc.
Several studies have reported that NMDA and non-NMDA receptor
antagonists, as well as NO inhibitors, were able to inhibit nociception
induced by acetic acid, formalin, and glutamate (Fundytus, 2001;
Jesse et al., 2009; Mohamad et al., 2010). In addition, Zhao et al.
(2008) showed that corilagin was able to suppress the release of pro-
inﬂammatory cytokines in vitro and reduced the production of NO
and other pro-inﬂammatory mediators. Our study demonstrates for
the ﬁrst time that intraperitoneal administration of corilagin pro-
duced marked and signiﬁcant dose-dependent suppression of noci-
ceptive responses in all chemical nociceptive test models used and
importantly, that no alteration in motor performance contributed to
the observed behaviors of the animals.
Exact mechanism underlying the anti-hyperalgesic effects of
corilagin remains unclear, but our results suggest that its anti-
hyperalgesic properties could be due in part to the inhibition of
NO production and release of pro-inﬂammatory mediators such
as cytokines as well as the potential interaction with the gluta-
matergic system.
Several studies from our and other research groups have
evidenced the antinociceptive activity of Phyllanthus niruri and
other species of the genus, sometimes attributing this effect to
both polar and non-polar compounds (Calixto et al., 1998).
However, this is the ﬁrst time that the antinociceptive potential
of corilagin is demonstrated.
Our ﬁndings presented herein are of interest because they
support the idea that corilagin, a tannin isolated from Phyllanthus
niruri, may be used for the development of potentially novel and
effective peripheral analgesics devoted to the control of pain.Acknowledgment
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